跳至主要内容
临床试验/ISRCTN14528733
ISRCTN14528733进行中(未招募)Unknown

Development and pilot feasibility testing of an intervention to support immunosuppression medication adherence in kidney transplant recipients

King's College London0 个研究点目标入组 80 人开始时间: 2024年5月13日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Phase 1 inclusion criteria:
  • 1. 18 years of age or over
  • 2. Living with kidney disease
  • 3. Speak and understand English
  • Phase 2 patient participant inclusion criteria:
  • 1. 18 years of age or over
  • 2. Living with a kidney transplant
  • 3. Prescribed immunosuppression medication.
  • 4. Read and speak English
  • 5. Evidence of sub-optimal immunosuppression medication adherence,i.e. a score of =23 on the Medication Adherence Rating Scale (MARS-5)
  • Phase 2 healthcare professional participant inclusion criteria:
  • 1. The healthcare professional is a consultant nephrologist, specialist renal transplant nurse, renal pharmacist or renal psychologist working in Guy’s Kidney Clinic.

排除标准

  • Phase 1 exclusion criteria:
  • 1. Currently under the care of a psychiatrist for a mental health condition
  • 2. Insufficient command of English
  • Phase 2 patient participant exclusion criteria:
  • 1. Currently under the care of a psychiatrist for a mental health condition
  • 2. Evidence of optimal immunosuppression medication adherence on the Medication Adherence Rating Scale (MARS-5), i.e. a total score of 24 or 25
  • 3. Insufficient command of English

研究者

相似试验